Cefpodoxime proxetil

头孢泊肟酯

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameCefpodoxime proxetil
Drug Alias Name丙酰氧乙酯CEPODEMcefpodoxima头孢多星吡决酯 +[20] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsUncomplicated skin and skin structure infectionsCommunity Acquired PneumoniaOtitis Media +[12] 
Global Approved IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial InfectionsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1992/08/07
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Representative Office Of Ramsey Lab Co Ltd India
Inactive CompaniesPfizer Inc
Active IndicationsBacterial Infections
Inactive IndicationsUncomplicated skin and skin structure infectionsCommunity Acquired PneumoniaOtitis Media +[11] 

Other Information

ATC CodeJ01DD13
Related LinksWikipediaDrugBankKEGG